Skip to main content
Caplight Logo









Brevel

Brevel

Private
IsraelHealthcare & Life Scienceshttps://brevel.co.il

Last Round

Grant

Jun 23, 2026

Total Funding Raised

$24.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Brevel operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in June 2026.

Brevel is a biotechnology company that develops an illuminated fermentation platform to produce sustainable, high-quality microalgae protein for the food, nutrition, and pharmaceutical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Brevel Comparables

Compare Brevel with similar companies based on industry and business-model similarity.

Brevel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sophie's Bionutrients
88%
Aliga Microalgae
86%
Solmeyea
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Brevel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2026
Seed ExtensionMar 24, 2025
SeedJul 25, 2023
GrantApr 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ido Golan

Co-Founder and CTO

Founding Team

Yonatan Golan

CEO

Executive Team

For institutional investors. Book with your work email.

Brevel Investors

Notable investors and investment history

Book a demo to see all 14 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 1518% MoM.

  • Jun 23, 2026

    $1M grant from Israel Innovation Authority

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • expands_facilitiesOct 26, 2026

    Brevel and The Wave Group are building a $15 million biomanufacturing facility in India with capacity for up to 300,000 liters of chlorella and other microalgae; construction is expected to take around 18 months.

  • invests_into_assetsOct 23, 2026

    Brevel's announcement estimates $10M to $15M in investment for the joint-venture facility in India, with construction expected to begin later in 2026.

  • expands_facilitiesOct 21, 2026

    Brevel partners with The Wave Group to develop a 300,000-liter full-production biomanufacturing facility in India, funded by The Wave Group, with construction starting in Oct '26 and full-scale production set to commence in Apr '28.

  • partners_withOct 21, 2026

    On Oct 21st '26 in India, Brevel partners with The Wave Group through a 50/50 joint venture to open a full-production biomanufacturing facility using illuminated fermentation technology, funded by The Wave Group and initially producing clean-label chlorella.

  • expands_facilitiesOct 21, 2026

    Brevel plans to expand its facilities in India through a 50/50 joint venture, developing a 300,000-liter illuminated-fermentation biomanufacturing site with an estimated USD10–15 million investment and full-scale production set to commence in Apr '28.

Book a demo to see all news

For institutional investors. Book with your work email.

Brevel Filings

Explore SEC and related filing metadata, where available.

Brevel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Brevel's valuation, stock price, and market status.

Is Brevel a public or private company?

Brevel is a private company.

What is the current stock price of Brevel?

Brevel is a private company, so its shares have no public market price. Caplight tracks Brevel's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Brevel worth (valuation)?

Valuation information for Brevel is not publicly available.

Can I buy Brevel stock?

Brevel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Brevel's last funding round?

Brevel's most recent funding round was Grant on June 23, 2026.

Who are the main investors in Brevel?

Key investors in Brevel include NevaTeam Partners, The Food Tech Lab.

Will Brevel IPO soon?

No public IPO plans have been announced for Brevel.

How can I track Brevel secondary market activity?

Caplight tracks bids, offers, and trades in Brevel's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range24
Year Founded2017
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?